The Food and Drug Administration’s head of vaccines and biotechnology drugs, Dr. Vinay Prasad, is leaving the agency as of April, following a series of clashes with the pharmaceutical industry in which he was accused of unfairly blocking or hamstringing approvals. A spokesperson for the Department of Health and Human Services confirmed to the Washington Examiner that Prasad would be leaving the agency at the end of March and FDA Commissioner Dr. Marty Makary is actively looking for replacements for the position. Prasad, whom Makary described last week on CNBC as being “on loan” from the Univer

The Food and Drug Administration’s head of vaccines and biotechnology drugs, Dr. Vinay Prasad, is leaving the agency as of April, following a series of clashes with the pharmaceutical industry in which he was accused of unfairly blocking or hamstringing approvals. A spokesperson for the Department of Health and Human Services confirmed to the Washington Examiner that Prasad would be leaving the agency at the end of March and FDA Commissioner Dr. Marty Makary is actively looking for replacements for the position. Prasad, whom Makary described last week on CNBC as being “on loan” from the Univer